Clinical Trials
2
Active:1
Completed:1
Trial Phases
2 Phases
Early Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (50.0%)Phase 2
1 (50.0%)Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Suzhou Municipal Hospital of Anhui Province
- Target Recruit Count
- 30
- Registration Number
- NCT06539260
- Locations
- 🇨🇳
Suzhou Hospital of Anhui Medical University, Suzhou, Anhui, China
Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment
Phase 2
Active, not recruiting
- Conditions
- Interleukin-6Ischemic StrokeEndovascular Treatment
- Interventions
- Drug: NaCl 0.9% 100ml
- First Posted Date
- 2024-02-02
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Suzhou Municipal Hospital of Anhui Province
- Target Recruit Count
- 108
- Registration Number
- NCT06238024
- Locations
- 🇨🇳
Suzhou Municipal Hospital of Anhui Province, Suzhou, Anhui, China
News
No news found